Basic Study
Copyright ©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1365-1381
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1365
Figure 3
Figure 3 Upregulating PPAR-γ activity ameliorates oxidative stress and NLRP3 inflammasome activation in lipid-laden hepatocytes. Primary hepatocytes were preincubated with the PPAR-γ agonist GW1929 for 3 h, followed by treatment with free fatty acids for 6 h for RT–PCR or 24 h for western blot and reactive oxygen species (ROS) detection. A: ROS production in primary hepatocytes; B: IL-1β production in the hepatocyte culture supernatant; C: mRNA expression of NLRP3 inflammasome-related genes in hepatocytes; D: Protein expression of NLRP3 inflammasome-related genes in hepatocytes; E: mRNA expression of Ppar-γ and oxidative stress-related genes in hepatocytes; F: Protein expression of oxidative stress-related genes in hepatocytes. Values are expressed as the mean ± SE of the mean, aP < 0.05, bP < 0.01 vs normal control; cP < 0.05, dP < 0.01 comparison of the designated two groups, n = 3 experiments. NC: Normal control; ROS: Reactive oxygen species; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; IL: Interleukin; Keap1: Kelch-like ECH-associated protein 1; Nrf2: NF-E2-related factor 2; Ho-1: Heme oxygenase-1; Nlrp3: NLR family pyrin domain-containing 3; Caspase-1: Cysteinyl aspartate-specific proteinase-1; Ppar-γ: Peroxisome proliferators-activated receptor-γ.